Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Modification of PLAC8 by UFM1 affects tumorous proliferation and immune response by impacting PD-L1 levels in triple-negative breast cancer
Misha Mao, Yongxia Chen, Jingjing Yang, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 12, pp. e005668-e005668
Open Access | Times Cited: 21

Showing 21 citing articles:

Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer
Moumita Kundu, Ramesh Butti, Venketesh K. Panda, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 41
Induction immunotherapy plus chemotherapy followed by definitive chemoradiation therapy in locally advanced esophageal squamous cell carcinoma: a propensity-score matched study
Hui‐min Lian, Jia-liang Wu, W.J. Liufu, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 3
Open Access | Times Cited: 8
Immunosuppressive role of SPP1-CD44 in the tumor microenvironment of intrahepatic cholangiocarcinoma assessed by single-cell RNA sequencing
Mei‐Ling Cheng, Guodong Liang, Zongyi Yin, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 9, pp. 5497-5512
Closed Access | Times Cited: 37
The UFM1 system: Working principles, cellular functions, and pathophysiology
Masaaki Komatsu, Toshifumi Inada, Nobuo N. Noda
Molecular Cell (2023) Vol. 84, Iss. 1, pp. 156-169
Open Access | Times Cited: 18
Ferroptosis as a promising targeted therapy for triple negative breast cancer
Kasra Mokhtarpour, Sepideh Razi, Nima Rezaei
Breast Cancer Research and Treatment (2024) Vol. 207, Iss. 3, pp. 497-513
Closed Access | Times Cited: 7
VCP/p97 UFMylation stabilizes BECN1 and facilitates the initiation of autophagy
Zhifeng Wang, Shuhui Xiong, Zhaoyi Wu, et al.
Autophagy (2024) Vol. 20, Iss. 9, pp. 2041-2054
Closed Access | Times Cited: 5
Ubiquitin modification in the regulation of tumor immunotherapy resistance mechanisms and potential therapeutic targets
Zihang Hong, Furong Liu, Zhanguo Zhang
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 5
The Post-Translational Role of UFMylation in Physiology and Disease
Xingde Wang, Xingzhi Xu, Zhifeng Wang
Cells (2023) Vol. 12, Iss. 21, pp. 2543-2543
Open Access | Times Cited: 11
UFMylation: An integral post-translational modification for the regulation of proteostasis and cellular functions
Xiaohui Wang, Xiaowei Lv, Jingjing Ma, et al.
Pharmacology & Therapeutics (2024) Vol. 260, pp. 108680-108680
Closed Access | Times Cited: 4
Identification and validation of immune and diagnostic biomarkers for interstitial cystitis/painful bladder syndrome by integrating bioinformatics and machine-learning
Tao Zhou, Can Zhu, Wei Zhang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
UFMylation in tumorigenesis: Mechanistic insights and therapeutic opportunities
Bingtao Liu, Tiantian Yang, Jialin Zhang, et al.
Cellular Signalling (2025), pp. 111657-111657
Closed Access
Diagnosis, Prognosis, and Treatment of Triple-Negative Breast Cancer: A Review
Huan Jie, Wenhui Ma, Cong Huang
Breast Cancer Targets and Therapy (2025) Vol. Volume 17, pp. 265-274
Open Access
Targeting “don’t eat me” signal: breast cancer immunotherapy
Yue Gao, Xiaoyan Zhang, Mingqiang Ding, et al.
Breast Cancer Research and Treatment (2025)
Closed Access
Microbiota-reprogrammed phosphatidylcholine inactivates cytotoxic CD8 T cells through UFMylation via exosomal SerpinB9 in multiple myeloma
Wei Yan, Xue Shi, Zhao Yun, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
The emerging roles of UFMylation in the modulation of immune responses
Zhengyan Liang, Rongxuan Ning, Zhao‐Xiang Wang, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 9
Open Access | Times Cited: 3
Plac8-ERK pathway modulation of monocyte function in sepsis
Teng Zhang, Jing-nan Fu, Guibing Chen, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Role of UFMylation in tumorigenesis and cancer immunotherapy
Lijuan Ding, Xin Jiang, Te Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Transcriptome wide functional analysis of HBx expressing human hepatocytes stimulated with endothelial cell cross-talk
Shaikh Maryam Ghufran, Prachi Sharma, Bornika Roy, et al.
Genomics (2023) Vol. 115, Iss. 4, pp. 110642-110642
Open Access | Times Cited: 3
PLAC8-Mediated Activation of NOX4 Signalling Restores Angiogenic Function of Endothelial Colony-Forming Cells in Experimental Hypoxia
Shun Hay Pun, Karla O’Neill, Kevin Edgar, et al.
Cells (2023) Vol. 12, Iss. 18, pp. 2220-2220
Open Access | Times Cited: 2
Mithramycin targets head and neck cancer stem cells by inhibiting Sp1 and UFMylation
Kristina Vuković Đerfi, Tea Vasiljević, Tea Dragičević, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access
Investigation of Underlying Biological Association and Targets between Rejection of Renal Transplant and Renal Cancer
Yinwei Chen, Zhanpeng Liu, Qian Yu, et al.
International Journal of Genomics (2023) Vol. 2023, pp. 1-19
Open Access | Times Cited: 1
Page 1

Scroll to top